Mitochondria are the primary metabolic engines of the cell, but when damaged by metabolic stress, hypoxia, or glucotoxicity, they become severe liabilities. Instead of efficiently producing ATP, dysfunctional mitochondria leak reactive oxygen species (ROS) and fragments of their own ancestral bacterial DNA (mitochondrial DNA, or mtDNA) into the cytosol.
As reviewed by Yonghu Chen et al. in Role of mitochondrial stress and the NLRP3 inflammasome in lung diseases, the cell perceives these leaked internal components as endogenous danger signals. This leakage triggers the assembly of the NLRP3 inflammasome, a multi-protein complex that initiates severe inflammatory cascades, leading to pyroptosis (inflammatory cell death) and chronic tissue damage. To prevent this, cells rely on mitophagy—the selective autophagic degradation of damaged mitochondria—as a critical homeostatic safety valve.
The Molecular Tagging System: How Cells Isolate Damaged Organelles
To maintain a healthy mitochondrial network, the cell must distinguish a functional, polarized mitochondrion from a damaged one. The primary mechanism relies on a molecular sensing circuit involving the PINK1 kinase and the Parkin ubiquitin ligase. Under normal conditions, PINK1 is continuously imported into healthy mitochondria and rapidly degraded. However, when a mitochondrion loses its membrane potential due to stress, import stalls, causing PINK1 to accumulate on the outer mitochondrial membrane.
As demonstrated by Xuanding Hei et al. in Mitophagy Regulation by Kangxian Yixin Granule in a Mouse Model of Dilated Cardiomyopathy, this accumulation acts as a molecular beacon that recruits Parkin from the cytosol to the damaged organelle. Parkin then ubiquitinates outer membrane proteins, effectively tagging the mitochondrion for engulfment by autophagosomes.
This pathway is a frequent target for therapeutic intervention. For instance, Qiaoru Wu et al. showed in Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease that restoring PINK1/Parkin-mediated mitophagy protects specialized kidney filtration cells (podocytes) from glucotoxic destruction by clearing dysfunctional organelles before they can trigger cellular death.
Energy Sensing and Upstream Regulation
Mitophagy does not operate in isolation; it is tightly coupled to the cell's overall energetic status via the AMPK/mTOR signaling axis. When a cell experiences metabolic deprivation or mitochondrial failure, ATP levels drop, activating the energy sensor AMPK. AMPK acts as a central coordinator of the mitochondrial life cycle, simultaneously stimulating mitochondrial fission to isolate damaged segments and activating the core autophagy machinery.
The therapeutic power of this axis is illustrated by Meichen Ma et al. in Metformin combined with rapamycin ameliorates podocyte injury in idiopathic membranous nephropathy through the AMPK/mTOR signaling pathway, where the synergistic activation of AMPK and inhibition of mTOR restored autophagic flux, thereby reducing local inflammation and renal fibrosis.
Similarly, Jinyoung Kim et al. demonstrated in An autophagy enhancer ameliorates diabetes of human IAPP-transgenic mice through clearance of amyloidogenic oligomer that enhancing autophagic pathways ensures the selective turnover of dysfunctional mitochondria. This mitochondrial rescue directly supports the high energy demands required for glucose-stimulated insulin secretion in secretory cells, demonstrating that structural cleanup is functionally linked to metabolic performance.
An Alternative Disposal Route: Extracellular Sequestration
While internal lysosomal degradation via autophagosomes is the classic pathway for mitophagy, recent discoveries reveal that highly mobile cells utilize an alternative, spatial strategy to shed mitochondrial waste. During migration, cells can sequester damaged mitochondria into specialized extracellular vesicles called migrasomes, which are left behind at the cell's trailing edge.
As synthesized by Jianyao Su et al. in Migrasomes as intercellular messengers: potential in the pathological mechanism, diagnosis and treatment of clinical diseases, this process acts as an external quality control mechanism. By shunting metabolic waste out of the main cell body during movement, active cells prevent the intracellular accumulation of stressors that lead to aging and dysfunction.
Zhiyong Tan et al. note in Migrasomes, critical players in intercellular communication that this specialized excretory mechanism allows highly active mobile cells, such as immune cells, to maintain metabolic viability under severe environmental stress by physically offloading compromised organelles into the extracellular environment.
Breaking the Cycle of Chronic Inflammation and Fibrosis
When mitophagy fails, the persistent activation of the NLRP3 inflammasome drives tissue remodeling and pathological scarring (fibrosis). Conversely, restoring mitophagy breaks this destructive cycle.
For example, Wenxiu He et al. demonstrated in Semaglutide ameliorates pressure overload-induced cardiac hypertrophy by improving cardiac mitophagy to suppress the activation of NLRP3 inflammasome that the GLP-1 receptor agonist semaglutide reverses cardiac hypertrophy by improving mitochondrial recycling. Crucially, when mitophagy was chemically blocked, the drug's protective benefits vanished, proving that organelle quality control is a strict prerequisite for structural protection against pressure-induced remodeling.
This protective paradigm extends across multiple organ systems:
- Glycemic Control: In environments marked by chronic high glucose, Kun Zhao et al. established in Bone marrow-derived mesenchymal stem cells ameliorate chronic high glucose-induced β-cell injury through modulation of autophagy that stem cell interventions protect pancreatic $\beta$-cells primarily by enhancing the clearance of damaged mitochondria, reducing oxidative stress, and restoring insulin secretion.
- Systemic Fibrosis: A comprehensive review on Exercise and tissue fibrosis: recent advances in therapeutic potential and molecular mechanisms highlights that physical exercise acts as a multi-organ therapeutic precisely because it induces autophagy and mitophagy. This cellular housekeeping clears the dysfunctional organelles and damaged proteins that would otherwise trigger the chronic inflammatory responses and subsequent extracellular matrix deposition characteristic of organ failure.
Ultimately, whether through small-molecule activation, stem cell signaling, or physiological stress like exercise, maintaining the rate of mitophagy ensures that the cellular mitochondrial population is continuously renewed. By isolating and recycling damaged components before they can leak endogenous danger signals, mitophagy serves as the primary shield against chronic inflammatory diseases and pathological tissue scarring.
Key Foundational Work
Bone marrow-derived mesenchymal stem cells ameliorate chronic high glucose-induced β-cell injury through modulation of autophagy (2015) — contributed 1 concept elements to this direction.